Table 3
Risk classification based on baseline testing
FISH indicates fluorescence in situ hybridization; MM, multiple myeloma; and PCLI, Plasma Cell Labeling index.
*Patients with t(4;14), β2 microglobulin < 4 mg/L and hemoglobin ≥ 10 g/dL may have intermediate risk disease.
#Shaughnessy et al,54 Decaux et al.55
